About: CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.77 (+5.76%)
CNSP NASDAQ CNS Pharmaceuticals Inc
CNS Pharmaceuticals Inc share price
Atividade de preço de CNSP
Último preço
$ 4,770
Variação (24h)
0,26 USD (5,77%)
Volume
46.37K
Volume (média 4 sem.)
-
Abertura
$ 4,60
Variação do dia
$ 4,35 - $ 5,19
Fechamento anterior
$ 4,51
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
CNSP price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals